Jason Bock, the co-founder and CEO of CTMC, advocates for a model of patient-adjacent manufacturing where industrial cell therapy manufacturing facilities are integrated with large medical centers.

Authors

• Person: Not available Organization: Drug Target Review
  New cell therapy model accelerates cancer treatment development

Sources

• New cell therapy model accelerates cancer treatment development www.drugtargetreview.com Drug Target Review via serper

Referenced by nodes (2)

• CTMC entity
• Jason Bock entity